Bruderman Asset Management’s Avanos Medical AVNS Stock Holding History

Bruderman Asset Management’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-25	Closed	-$1K	–	146
2019 Q1	$1K	Hold	25	–	–	﹤0.01%	591
2018 Q4	$1K	Hold	25	–	–	﹤0.01%	596
2018 Q3	$2K	Hold	25	–	–	﹤0.01%	332
2018 Q2	$1K	Hold	25	–	–	﹤0.01%	358
2018 Q1	$1K	Buy	+25	New	+$1.19K	﹤0.01%	342
2017 Q3	–	Sell	-25	Closed	-$1K	–	134
2017 Q2	$1K	Buy	+25	New	+$945	﹤0.01%	352
2017 Q1	–	Sell	-25	Closed	-$1K	–	129
2016 Q4	$1K	Sell	25 -30	-55%	-$1.07K	﹤0.01%	356
2016 Q3	$2K	Sell	55 -75	-58%	-$2.63K	﹤0.01%	366
2016 Q2	$4K	Hold	130	–	–	﹤0.01%	344
2016 Q1	$4K	Hold	130	–	–	﹤0.01%	364
2015 Q4	$4K	Hold	130	–	–	﹤0.01%	374
2015 Q3	$4K	Sell	130 -94	-42%	-$3.28K	﹤0.01%	384
2015 Q2	$9K	Sell	224 -14	-6%	-$628	﹤0.01%	355
2015 Q1	$12K	Buy	+238	New	+$11K	﹤0.01%	328

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bruderman Asset Management's AVNS Position: Q2 2019 in Review

Bruderman Asset Management sold out of Avanos Medical (AVNS) in Q2 2019, closing a stake of 25 shares — an estimated $1K sold.

Bruderman Asset Management first reported a position in AVNS in Q1 2015 and held it in 14 quarters. The position peaked at $12K in Q1 2015. 317 funds tracked by Wall St. Rank hold AVNS as of Q2 2019.

Bruderman Asset Management reported no remaining Avanos Medical position as of Q2 2019 after selling out during the quarter.
Bruderman Asset Management sold 25 Avanos Medical shares in Q2 2019, an estimated $1K.
Bruderman Asset Management first reported a position in Avanos Medical in Q1 2015 and held it in 14 quarters.
Bruderman Asset Management's Avanos Medical position peaked at $12K in Q1 2015.
317 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2019.

Based on Bruderman Asset Management's 13F filing for Q2 2019, filed 12 Aug 2019.